NEW YORK – Microbiology labs are frequently asked to do more with less, and the SARS-CoV-2 pandemic has provided even greater challenges for directors as they have tried to keep up with the pace of test volume, supply shortages, and a lack of enough trained personnel to conduct molecular testing.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.